Evidence map›Paper›PMID 27083998›Full record

ArticleGenes & development2016

USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response.

Zhiquan Wang, Honglian Zhang, Ji Liu, Abigael Cheruiyot, Jeong-Heon Lee, Tamas Ordog, Zhenkun Lou, Zhongsheng You, Zhiguo Zhang

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhiquan WangDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA;
Honglian ZhangDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA;
Ji LiuDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA;
Abigael CheruiyotDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA;
Jeong-Heon LeeDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA; Center for Individualized Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA;
Tamas OrdogCenter for Individualized Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA;
Zhenkun LouDivision of Oncology Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Zhongsheng YouDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA;
Zhiguo ZhangDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA; Center for Individualized Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA;
Mayo Clinic · USWashington University in St. Louis · US

Funding

Physiological Characterization and Data Integration CoreP01DK068055 · NIDDK · MAYO CLINIC ROCHESTER · PI BHARUCHA, ADIL E. · 2004 to 2019
$23.8M
Mechanisms of Epigenetic inheritanceR35GM118015 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Zhiguo Zhang · 2016 to 2026
$9.5M
MOLECULAR MECHANISMS OF DNA DAMAGE SIGNALING AND REPAIRR01GM098535 · NIGMS · WASHINGTON UNIVERSITY · PI PISTON, DAVID W · 2012 to 2025
$4.2M
Ubiquitination and the DNA Damage Response PathwayR01CA130996 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2008 to 2018
$3.3M
Regulation of Nucleosome AssemblyR01GM081838 · NIGMS · MAYO CLINIC ROCHESTER · PI ZHANG, ZHIGUO · 2008 to 2015
$2.4M
Regulation of homologous recombination and cancer cell response to chemoradiotherapyR01CA203561 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2016 to 2020
$1.8M
The role of a histone H4 phosphorylation in drug resistanceR01CA157489 · NCI · MAYO CLINIC ROCHESTER · PI ZHANG, ZHIGUO · 2012 to 2016
$1.6M
NCI NIH HHS CA157489NCI NIH HHS R01 CA130996NCI NIH HHS R01 CA157489NCI NIH HHS R01 CA203561NIDDK NIH HHS P01 DK068055NIGMS NIH HHS GM098535NIGMS NIH HHS GM81838NIGMS NIH HHS R01 GM081838NIGMS NIH HHS R01 GM098535NIGMS NIH HHS R35 GM118015
6 · The paper itself

Abstract

Dynamic regulation of RNF168-mediated ubiquitylation of histone H2A Lys13,15 (H2AK13,15ub) at DNA double-strand breaks (DSBs) is crucial for preventing aberrant DNA repair and maintaining genome stability. However, it remains unclear which deubiquitylating enzyme (DUB) removes H2AK13,15ub. Here we show that USP51, a previously uncharacterized DUB, deubiquitylates H2AK13,15ub and regulates DNA damage response. USP51 depletion results in increased spontaneous DNA damage foci and elevated levels of H2AK15ub and impairs DNA damage response. USP51 overexpression suppresses the formation of ionizing radiation-induced 53BP1 and BRCA1 but not RNF168 foci, suggesting that USP51 functions downstream from RNF168 in DNA damage response. In vitro, USP51 binds to H2A-H2B directly and deubiquitylates H2AK13,15ub. In cells, USP51 is recruited to chromatin after DNA damage and regulates the dynamic assembly/disassembly of 53BP1 and BRCA1 foci. These results show that USP51 is the DUB for H2AK13,15ub and regulates DNA damage response.

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsCell Line, TumorCell SurvivalDNADNA DamageDNA RepairHistonesHumansNuclear ProteinsProtein BindingRadiation, IonizingTrans-ActivatorsUbiquitinationUbiquitin-Specific ProteasesAdaptor Proteins, Signal TransducingCell Cycle ProteinsDNAHistonesMDC1 protein, humanNuclear ProteinsTrans-ActivatorsUbiquitin-Specific ProteasesUSP51 protein, humandeubiqutylating enzymeDNA damage responseH2AK15ubUSP51

Identifiers

PMID27083998
PMCPMC4840300
OpenAlexW2341928372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.